Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2019 2
2020 1
2021 2
2022 4
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Charting the Fragmented Landscape of Drug Synergy.
Meyer CT, Wooten DJ, Lopez CF, Quaranta V. Meyer CT, et al. Trends Pharmacol Sci. 2020 Apr;41(4):266-280. doi: 10.1016/j.tips.2020.01.011. Epub 2020 Feb 26. Trends Pharmacol Sci. 2020. PMID: 32113653 Free PMC article. Review.
Activation of STAT3 through combined SRC and EGFR signaling drives resistance to a mitotic kinesin inhibitor in glioblastoma.
Kenchappa RS, Dovas A, Argenziano MG, Meyer CT, Stopfer LE, Banu MA, Pereira B, Griffith J, Mohammad A, Talele S, Haddock A, Zarco N, Elmquist W, White F, Quaranta V, Sims P, Canoll P, Rosenfeld SS. Kenchappa RS, et al. Among authors: meyer ct. Cell Rep. 2022 Jun 21;39(12):110991. doi: 10.1016/j.celrep.2022.110991. Cell Rep. 2022. PMID: 35732128 Free PMC article.
High Throughput Viability Assay for Microbiology.
Meyer CT, Lynch GK, Stamo DF, Miller EJ, Chatterjee A, Kralj JM. Meyer CT, et al. bioRxiv [Preprint]. 2023 Jan 4:2023.01.04.522767. doi: 10.1101/2023.01.04.522767. bioRxiv. 2023. PMID: 36712102 Free PMC article. Updated. Preprint.
Translatome proteomics identifies autophagy as a resistance mechanism to on-target FLT3 inhibitors in acute myeloid leukemia.
Koschade SE, Klann K, Shaid S, Vick B, Stratmann JA, Thölken M, Meyer LM, Nguyen TD, Campe J, Moser LM, Hock S, Baker F, Meyer CT, Wempe F, Serve H, Ullrich E, Jeremias I, Münch C, Brandts CH. Koschade SE, et al. Among authors: meyer ct. Leukemia. 2022 Oct;36(10):2396-2407. doi: 10.1038/s41375-022-01678-y. Epub 2022 Aug 23. Leukemia. 2022. PMID: 35999260 Free PMC article.
MuSyC dosing of adjuvanted cancer vaccines optimizes antitumor responses.
Taylor D, Meyer CT, Graves D, Sen R, Fu J, Tran E, Mirza B, Rodriguez G, Lang C, Feng H, Quaranta V, Wilson JT, Kim YJ, Korrer MJ. Taylor D, et al. Among authors: meyer ct. Front Immunol. 2022 Aug 19;13:936129. doi: 10.3389/fimmu.2022.936129. eCollection 2022. Front Immunol. 2022. PMID: 36059502 Free PMC article.
A high-throughput and low-waste viability assay for microbes.
Meyer CT, Lynch GK, Stamo DF, Miller EJ, Chatterjee A, Kralj JM. Meyer CT, et al. Nat Microbiol. 2023 Dec;8(12):2304-2314. doi: 10.1038/s41564-023-01513-9. Epub 2023 Nov 2. Nat Microbiol. 2023. PMID: 37919425 Free PMC article.
Quantifying Drug Combination Synergy along Potency and Efficacy Axes.
Meyer CT, Wooten DJ, Paudel BB, Bauer J, Hardeman KN, Westover D, Lovly CM, Harris LA, Tyson DR, Quaranta V. Meyer CT, et al. Cell Syst. 2019 Feb 27;8(2):97-108.e16. doi: 10.1016/j.cels.2019.01.003. Epub 2019 Feb 20. Cell Syst. 2019. PMID: 30797775 Free PMC article.
17 results